Tuberculosis is a high-mortality infectious disease. Manual sputum smear microscopy is a common and effective method for screening tuberculosis. However, it is time-consuming, labor-intensive, and has low sensitivity. In this study, we propose ResGloTBNet, a framework that integrates convolutional neural network and graph convolutional network for sputum smear image classification with high discriminative power. In this framework, the global reasoning unit is introduced into the residual structure of ResNet to form the ResGloRe module, which not only fully extracts the local features of the image but also models the global relationship between different regions in the image. Furthermore, we applied activation maximization and class activation mapping to generate explanations for the model's predictions on the test sets. ResGloTBNet achieved remarkable results on a publicly available dataset, reaching 97.2 % accuracy and 99.0 % sensitivity. It also maintained a high level of performance on a private dataset, attaining 98.0 % accuracy and 96.6 % sensitivity. In addition, interpretable analysis demonstrated that ResGloTBNet can effectively identify the features and regions in the input images that contribute the most to the model's predictions, providing valuable insights into the decision-making process of the deep learning model.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.medengphy.2025.104300 | DOI Listing |
Open Forum Infect Dis
March 2025
National Institutes of Health-NIAID-International Center for Excellence in Research, Chennai, India.
Background: This study investigates how (Ss) infection impacts pulmonary tuberculosis (PTB) treatment outcomes, disease severity, and bacterial burdens in PTB patients with Ss coinfection.
Methods: We used chest x-rays and sputum smear grades to assess lung conditions and bacterial loads in 483 PTB patients. Ss infection was confirmed by seropositivity, and cytokine and profibrotic factor levels were analyzed using multiplex enzyme-linked immunosorbent assay.
Nurs Health Sci
March 2025
Department of Medical Nursing, Faculty of Nursing, Mahidol University, Bangkok, Thailand.
This systematic review evaluates the application of machine learning (ML) models for diagnosing pulmonary tuberculosis and their potential to inform nursing practice and implementation strategies. Studies published between 2019 and 2024 were systematically identified through searches in Scopus, PubMed, Medline, ScienceDirect, CINAHL Plus with Full Text, Clinical Key, Ovid, EMBASE, and Web of Science. The review adhered to PRISMA guidelines, with rigorous inclusion and exclusion criteria applied.
View Article and Find Full Text PDFMed Eng Phys
March 2025
Medical Data Science Academy, College of Medical Informatics, Chongqing Medical University, Chongqing 400016, China. Electronic address:
Tuberculosis is a high-mortality infectious disease. Manual sputum smear microscopy is a common and effective method for screening tuberculosis. However, it is time-consuming, labor-intensive, and has low sensitivity.
View Article and Find Full Text PDFJ Infect Public Health
February 2025
Institute for Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address:
Background: Disagreement persists regarding the cause of death in patients with tuberculosis (TB) between the national TB registry and vital registration statistics. This study investigated the disagreement and contributing factors between TB-related and non-TB-related deaths using an integrated national TB database in South Korea.
Methods: We identified a sub-set cohort of 29,033 patients with drug-susceptible TB registered between 2011 and 2020 who died during TB treatment.
Front Cell Infect Microbiol
March 2025
Department of TB Diseases, Affiliated Infectious Diseases Hospital of Zhengzhou University, Zhengzhou, China.
Background: Traditional lipoarabinomannan tests have limited sensitivity in HIV-negative individuals. Our aims were to compare chemiluminescence-based LAM (AIMLAM) and other diagnostic modalities in HIV-negative patients and to explore whether lymphocyte counts impact the sensitivity and costs of AIMLAM.
Methods: This is a prospective, cross-sectional, diagnostic accuracy study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!